张昊文,刘红莉

心房颤动是冠心病患者发生死亡、脑卒中这类不良事件的独立预测因素。针对这一特殊人群开展抗栓治疗，是临床上的难点与热点问题：既要考虑抗血小板治疗，又要考虑抗凝治疗，同时还需避免出血情况的发生。目前，关于冠心病合并房颤患者抗栓现状及预后的相关研究已取得显著进展。本文将对房颤合并冠心病患者经皮冠状动脉介入治疗术后的抗栓治疗方案展开深入研究，旨在探寻更为安全有效的治疗策略。

心房颤动；冠心病；经皮冠状动脉介入治疗；抗栓方案

[1] ANDRADE JG,DEYELL MW,WONG GC,et al.Antithrombotic Therapy for Atrial Fibrillation and Coronary Disease Demystified[J]. Can J Cardiol,2018,34(11):1426-1436. [2] ZOGRAFOS TA,KATRITSIS DG.Selection of Antithrombotic Therapy in Patients with Atrial Fibrillation and Percutaneous Coronary Intervention[J].Curr Pharm Des,2016,22(29):4604-4609. [3] BOCCHINO PP,ANGELINI F,TOSO E.Atrial fibrillation and coronary artery disease:a review on the optimal use of oral anticoagulants[J].Rev Cardiovasc Med,2021,22(3):635-648. [4] BENNAGHMOUCH N,DEWILDE WJ,TEN BERG JM.Triple therapy for atrial fibrillation and percutaneous coronary intervention[J]. Curr Opin Cardiol,2015,30(6):690-698. [5] GWYN JCV,THOMAS MR,KIRCHHOF P.Triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention:a viewpoint[J].Eur Heart J Cardiovasc Pharmacother,2017,3(3):157-162. [6] BENCIVENGA L,KOMICI K,CORBI G,et al.The Management of Combined Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention:A Particularly Complex Challenge,Especially in the Elderly[J].Front Physiol, 2018,9:876. [7] GOETTE A,VRANCKX P.Atrial fibrillation patients undergoing percutaneous coronary intervention:dual or triple antithrombotic therapy with non-vitamin K antagonist oral anticoagulants[J].Eur Heart J Suppl,2020,22(Suppl I):I22-I31. [8] MISHRA A,SINGH M,ACKER WW,et al.Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention[J].J Cardiovasc Pharmacol,2019,74(2):82-90. [9] MAGNANI G,ARDISSINO D,IM K,et al.Predictors,Type,and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction[J].J Am Heart Assoc,2021,10(4):e017008. [10] ALSHAHRANI A,O'NUNAIN S.Is triple antithrombotic therapy a safe option in patients with AF who receive drug-eluting stents?:a review article[J].Egypt Heart J,2023,75(1):74. [11] ATHER A,LALIBERTE B,REED BN,et al.Antithromboembolic Strategies for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention[J].Am J Cardiovasc Drugs,2018,18(6):441-455. [12] CANNON CP.Role and Timing of Aspirin Therapy Following PCI in Patients With Atrial Fibrillation[J].Am J Cardiol,2021,144 Suppl 1:S32-S39. [13] DE LUCA L,MISTRULLI R,VENEZIANO FA,et al.Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention[J].J Clin Med,2022,11(3):512. [14] GARGIULO G,GOETTE A,TIJSSEN J,et al.Safety and efficacy outcomes of double vs.triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention:a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials[J].Eur Heart J,2019,40(46):3757-3767. [15] CAPODANNO D,DI MAIO M,GRECO A,et al.Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention:A Systematic Review and Meta-Analysis[J].J Am Heart Assoc,2020,9(16):e017212. [16] PRADHAN A,BHANDARI M,VISHWAKARMA P,et al.Novel Dual Therapy:A Paradigm Shift in Anticoagulation in Patients of Atrial Fibrillation Undergoing Percutaneous Coronary Intervention[J].TH Open,2020,4(4):e332-e343. [17] DUERSCHMIED D,BRACHMANN J,DARIUS H,et al.Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention:should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?[J].Clin Res Cardiol,2018,107(7):533-538. [18] SCHÄFER A,FLIERL U,BAUERSACHS J.Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI[J].Clin Res Cardiol,2021,110(6):759-774. [19] VALGIMIGLI M,LANDI A,ANGIOLILLO DJ,et al.Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome[J].Circulation,2024,150(4):317-335. [20] MURTHY SB,ZHANG C,SHAH S,et al.Antithrombotic and Statin Prescription After Intracerebral Hemorrhage in the Get With The Guidelines-Stroke Registry[J].Stroke,2023,54(12):2972-2980.

点击下载PDF